论文部分内容阅读
本研究应用中药心肌康对左心室肥厚（ＬＶＨ）患者进行逆转性治疗。９４例ＬＶＨ患者随机分为心肌康治疗组（７４例）和美多心安对照组（２０例），作服药前后的临床疗效观察。结果表明：心肌康对ＬＶＨ有显著的退缩作用（Ｐ＜０．０５，Ｐ＜０．０１），对照组对ＬＶＨ的治疗虽有一定程度的改善，但无统计学意义，两组于治疗后比较亦呈显著性差异（Ｐ＜０．０１）。心肌康对ＬＶＨ的病因具有缓解或消除的作用，如心功能和微循环的改善，血粘度、血载脂蛋白Ａ－１（ＡＰＯＡ－１）、心肌耗氧量（ＲＰＰ）的降低和超氧化物歧化酶（ＳＯＤ）升高等，治疗前后均有显著性差异，与对照组比较，亦具有统计学意义（Ｐ＜０．０５或Ｐ＜０．０１）。上述结果提示心肌康对ＬＶＨ具有一定的逆转作用。
In this study, the application of traditional Chinese medicine IKK on patients with left ventricular hypertrophy (LVH) reversal treatment. Ninety-four patients with LVH were randomly divided into two groups, namely, Xinjikang group (74 cases) and Metoprolol group (20 cases) for clinical observation. The results showed that: myocardial glycogen significantly retarded LVH (P <0.05, P <0.01), while the control group for the treatment of LVH although some degree of improvement, but no statistical significance, both groups after treatment Comparison also showed significant difference (P <0.01). Myocardial health effects of LVH eased or eased, such as improvement of cardiac function and microcirculation, blood viscosity, apolipoprotein A-1 (APOA-1), myocardial oxygen consumption (RPP) decreased and superoxide Compared with the control group, there was also a significant difference between before and after treatment (P <0.05 or P <0.01). The above results suggest that myocardial Kang has a certain reversal of LVH.